Array Technologies Inc
For the period ended Dec 31, 2023. Filed Feb 28, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 28, 2024
ARRY$4.73-8.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Cash Flows F-
Consolidated Statements of Cash Flows
| Year Ended December 31, | |||
|---|---|---|---|
| 2023 | 2022 | 2021 | |
| Operating activities: | |||
| Net income (loss) | $137,240 | $4,432 | $(50,403) |
| Adjustments to net income (loss): | |||
| Provision for (recovery of) bad debts | 2,527 | 2,599 | (467) |
| Deferred tax benefit | (8,862) | (31,565) | (10,102) |
| Depreciation and amortization | 40,268 | 86,501 | 11,388 |
| Amortization of developed technology | 14,558 | 14,558 | 14,558 |
| Amortization of debt discount and issuance costs | 10,570 | 6,857 | 15,036 |
| Gain on debt refinancing | (457) | — | — |
| Equity-based compensation | 14,540 | 14,982 | 13,757 |
| Contingent consideration | 2,964 | (4,507) | 2,696 |
| Warranty provision | 4,666 | 4,152 | 516 |
| Write-down of inventories | 6,431 | (859) | 990 |
| Changes in operating assets and liabilities, net of business acquisition: | |||
| Accounts receivable | 92,800 | (76,984) | (116,848) |
| Inventories | 66,743 | 20,870 | (88,184) |
| Income tax receivables | 9 | 5,611 | 8,106 |
| Prepaid expenses and other | (10,840) | 19,124 | (21,226) |
| Accounts payable | (37,654) | 12,667 | 7,015 |
| Accrued expenses and other | 5,325 | 1,024 | 9,133 |
| Income tax payable | 1,936 | (755) | (8,754) |
| Lease liabilities | 1,177 | 3,784 | 221 |
| Deferred revenue | (111,986) | 59,002 | (50,619) |
| Net cash provided by (used in) operating activities | 231,955 | 141,493 | (263,187) |
| Investing activities: | |||
| Purchase of property, plant and equipment | (16,989) | (10,619) | (3,357) |
| Retirement/disposal of PP&E | 168 | — | — |
| Acquisition of STI, net of cash acquired | — | (373,818) | — |
| Investment in equity securities | — | — | (11,975) |
| Net cash used in investing activities | (16,821) | (384,437) | (15,332) |
| Financing activities: | |||
| Proceeds from Series A issuance | — | 33,098 | 224,987 |
| Proceeds from common stock issuance | — | 15,885 | 120,645 |
| Series A equity issuance costs and commitment fees | (1,509) | (1,893) | (7,195) |
| Common stock issuance costs | — | (450) | (3,873) |
Consolidated Statements of Cash Flows(continued)
| Year Ended December 31, | |||
|---|---|---|---|
| 2023 | 2022 | 2021 | |
| Dividends paid on Series A Preferred | — | (18,670) | (8,051) |
| Payments on revolving credit facility | — | (116,000) | (126,033) |
| Proceeds from revolving credit facility | — | 116,000 | 126,033 |
| Proceeds from issuance of other debt | 63,311 | 20,188 | — |
| Proceeds from issuance of convertible notes | — | — | 413,321 |
| Premium paid on capped call | — | — | (52,870) |
| Fees paid on issuance of convertible notes | — | — | (1,591) |
| Principal payments on term loan facility | (74,300) | (14,300) | — |
| Principal payments on other debt | (88,063) | (23,935) | (133,225) |
| Contingent consideration payments | (1,200) | (1,483) | (7,810) |
| Debt issuance costs | — | — | (6,590) |
| Net cash (used in) provided by financing activities | (101,761) | 8,440 | 537,748 |
| Effect of exchange rate changes on cash and cash equivalent balances | 1,806 | 735 | — |
| Net change in cash and cash equivalents | 115,179 | (233,769) | 259,229 |
| Cash and cash equivalents, beginning of period | 133,901 | 367,670 | 108,441 |
| Cash and cash equivalents, end of period | $249,080 | $133,901 | $367,670 |
| Supplemental Cash Flow Information | |||
| Cash paid for interest | $43,949 | $23,118 | $24,306 |
| Cash paid for income taxes | $45,942 | $10,739 | $13,318 |
| Non-cash Investing and Financing Activities | |||
| Dividends accrued on Series A Preferred | $26,370 | $6,389 | $— |
| Stock consideration paid for acquisition of STI | $— | $200,224 | $— |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.